Recently, a study demonstrated that low level of expression of the tumor-suppressor, miR-196b can cause up-regulation of BCR-ABL1 expression which leads to the development of CML [55]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.